The U.S. Patent and Trademark Office is delaying patent-related fee increases by about three months in light of the coronavirus-related economic downturn.
The agency on Friday announced it would increase a slew of fees associated with issuing and maintaining patent rights and Patent Trial and Appeal Board validity trials. Among the hikes is an increase from $15,500 to $19,000 for large companies requesting an inter partes review of up to 20 patent claims.
The PTO had planned to put the changes into effect this month but pushed implementation back to Oct. 2, citing “the state of the U.S. economy” as ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.